Can metoprolol be crushed safely. What are the differences between metoprolol tartrate and succinate. How to properly administer metoprolol for patients with difficulty swallowing. What are the risks of crushing extended-release medications.

Understanding Metoprolol: Tartrate vs. Succinate

Metoprolol is a widely prescribed beta-blocker used to treat various cardiovascular conditions. However, not all forms of metoprolol are created equal when it comes to administration methods. There are two main types of metoprolol available:

• Metoprolol tartrate (immediate-release)
• Metoprolol succinate (extended-release)

Understanding the differences between these two forms is crucial for proper administration and ensuring optimal therapeutic effects.

Metoprolol Tartrate: The Crushable Option

Metoprolol tartrate, commonly known by its brand name Lopressor, is an immediate-release formulation. This means that the medication is designed to release its active ingredients quickly after ingestion. Due to its formulation, metoprolol tartrate can be safely crushed without altering its effectiveness or pharmacokinetics.

Metoprolol Succinate: Handle with Care

On the other hand, metoprolol succinate, marketed under the brand name Toprol XL, is an extended-release formulation. This version of the medication is designed to release its active ingredients slowly over time, providing a sustained therapeutic effect. Because of its specialized delivery mechanism, metoprolol succinate should not be crushed.

The Science Behind Crushing Medications

Why is it safe to crush some medications but not others? The answer lies in the pharmaceutical design and the intended release mechanism of the drug.

Immediate-Release Formulations

Immediate-release medications, like metoprolol tartrate, are designed to dissolve quickly in the gastrointestinal tract. Crushing these tablets does not significantly alter their absorption or effectiveness. In fact, crushing can sometimes be beneficial for patients who have difficulty swallowing whole tablets.

Extended-Release Formulations

Extended-release medications, such as metoprolol succinate, are engineered to release the active ingredient gradually over time. This controlled release is achieved through various mechanisms, often involving specialized coatings or matrix systems within the tablet. Crushing these formulations can destroy the extended-release mechanism, leading to a rapid release of the entire dose at once. This can potentially cause adverse effects or reduce the medication’s efficacy over time.

The Unique Case of Metoprolol Succinate

While most extended-release medications cannot be split or crushed, metoprolol succinate presents an interesting exception to this rule.

Splitting vs. Crushing

Metoprolol succinate tablets are scored and can be safely split in half. This unique feature is due to the tablet’s design, which contains multiple controlled-release pellets evenly distributed throughout the tablet. Each pellet acts as an individual delivery device, allowing the tablet to be split without compromising its extended-release properties.

However, it’s crucial to note that while splitting is permissible, crushing metoprolol succinate tablets remains strictly prohibited. Crushing would destroy the controlled-release pellets, leading to an immediate release of the entire dose.

Proper Administration Techniques for Metoprolol

Ensuring proper administration of metoprolol is essential for its effectiveness and patient safety. Here are some guidelines for different scenarios:

For Patients Who Can Swallow Tablets

• Metoprolol tartrate: Take the tablet whole with water, or crush if necessary.
• Metoprolol succinate: Take the tablet whole with water. If needed, split along the score line, but never crush.

For Patients with Swallowing Difficulties

• Metoprolol tartrate: Crush the tablet and mix with a small amount of soft food or liquid.
• Metoprolol succinate: Consult a healthcare provider for alternative formulations or administration methods.

For Patients with Feeding Tubes

• Metoprolol tartrate: Crush the tablet finely and mix with water before administering through the feeding tube.
• Metoprolol succinate: Do not administer through a feeding tube. Consult a healthcare provider for alternative options.

Risks and Considerations When Crushing Medications

While crushing certain medications can be safe and necessary in some cases, it’s important to understand the potential risks and considerations associated with this practice.

Potential Risks of Crushing Extended-Release Medications

• Dose dumping: Rapid release of the entire medication dose, potentially leading to toxicity or adverse effects.
• Reduced efficacy: The medication may not maintain therapeutic levels over the intended duration.
• Altered pharmacokinetics: Changes in how the body absorbs, distributes, metabolizes, and eliminates the drug.
• Gastrointestinal irritation: Some medications are coated to protect the stomach lining, and crushing may negate this protection.

Considerations for Healthcare Providers

When faced with patients who have difficulty swallowing medications, healthcare providers should consider the following options:

1. Explore alternative formulations (e.g., liquid, dispersible tablets, or transdermal patches).
2. Consider therapeutic alternatives that can be safely crushed or are available in different forms.
3. Consult with a pharmacist to determine if a liquid formulation can be extemporaneously prepared.
4. In some cases, after careful consideration of compatibility and stability, an injectable formulation may be used.

Importance of Patient Education and Communication

Proper patient education is crucial when it comes to medication administration, especially for drugs like metoprolol that have different formulations with distinct handling requirements.

Key Points for Patient Education

• Explain the difference between immediate-release and extended-release formulations.
• Emphasize the importance of taking the medication exactly as prescribed.
• Teach patients how to properly split metoprolol succinate tablets if necessary.
• Warn against crushing extended-release formulations without consulting a healthcare provider.
• Encourage patients to ask questions about their medications and report any difficulties with administration.

Role of Healthcare Providers

Healthcare providers play a critical role in ensuring safe and effective medication use. They should:

• Assess each patient’s ability to swallow medications and tailor prescriptions accordingly.
• Provide clear, written instructions on how to take the medication properly.
• Be available to answer questions and address concerns about medication administration.
• Regularly review patients’ medication regimens to ensure they are still appropriate and manageable.

Alternatives to Crushing Medications

When patients have difficulty swallowing tablets or capsules, there are several alternatives to consider before resorting to crushing medications:

Alternative Formulations

• Liquid formulations: Many medications are available as syrups, suspensions, or solutions.
• Dispersible tablets: These can be dissolved in water before administration.
• Transdermal patches: Some medications can be delivered through the skin.
• Sublingual or buccal tablets: These dissolve under the tongue or between the gum and cheek.
• Orally disintegrating tablets: These dissolve rapidly in the mouth without water.

Swallowing Techniques

For patients who struggle with swallowing tablets, certain techniques can be helpful:

• The “lean forward” method: Tilt the chin towards the chest and swallow.
• The “pop bottle” method: Place the tablet on the tongue, close lips tightly around a plastic bottle opening, and suck while swallowing.
• Using thicker liquids: Swallowing tablets with applesauce or yogurt instead of water can be easier for some patients.

Legal and Ethical Considerations in Medication Modification

The practice of crushing or modifying medications raises several legal and ethical considerations that healthcare providers must be aware of:

Off-Label Use

Crushing or altering a medication’s form may be considered off-label use, which can have legal implications. Healthcare providers should document the rationale for such decisions and obtain informed consent when appropriate.

Liability Concerns

Healthcare providers may be held liable for adverse events resulting from improperly modified medications. It’s crucial to follow established guidelines and consult with pharmacists or other specialists when in doubt.

Patient Autonomy and Informed Consent

Patients have the right to make informed decisions about their treatment. When medication modification is necessary, healthcare providers should explain the reasons, potential risks, and alternatives to ensure patients can provide informed consent.

Institutional Policies

Many healthcare institutions have specific policies regarding medication modification. Healthcare providers should familiarize themselves with these policies and adhere to them to ensure consistent and safe practice.

Future Developments in Medication Formulations

As the pharmaceutical industry continues to innovate, new formulations and technologies are emerging to address the challenges of medication administration:

Advanced Drug Delivery Systems

• 3D-printed medications: Customized dosage forms tailored to individual patient needs.
• Nanotechnology-based formulations: Improved bioavailability and targeted drug delivery.
• Smart pill technologies: Medications with embedded sensors to track adherence and efficacy.

Patient-Centric Designs

Pharmaceutical companies are increasingly focusing on developing formulations that are easier for patients to take, such as:

• More palatable liquid formulations
• Improved orally disintegrating tablets
• Novel transdermal delivery systems
• Inhalable formulations for systemic drug delivery

These advancements aim to reduce the need for crushing or modifying medications, ultimately improving patient adherence and outcomes.

In conclusion, understanding the proper administration of medications like metoprolol is crucial for ensuring patient safety and therapeutic efficacy. While metoprolol tartrate can be safely crushed, metoprolol succinate requires special handling due to its extended-release formulation. Healthcare providers and patients must work together to find the most appropriate administration method for each individual case, considering alternative formulations and techniques when necessary. As pharmaceutical technology advances, we can expect to see more patient-friendly formulations that address the challenges of medication administration, potentially reducing the need for medication modification in the future.

Can You Crush Metoprolol? | HelloPharmacist

Key points

• There are two different forms of metoprolol available, metoprolol succinate and metoprolol tartrate.
• Metoprolol tartrate can be crushed while metoprolol succinate (an extended-release product) cannot.

Hello and thanks for reaching out!

The answer to this depends on which form of metoprolol you are talking about, as it is available as:

• Metoprolol tartrate
• Metoprolol succinate

Metoprolol tartrate is an immediate-release version of the drug while metoprolol succinate is the extended-release version.

Which Can You Crush?

Metoprolol tartrate (generic for Lopressor) can safely be crushed. Doing so will not alter how the medication works

Metoprolol succinate (generic for Toprol XL) on the other hand, cannot be crushed as it is an extended-release product. Doing so will destroy the extended-release mechanism, causing all of the medication to be released at once.

Interesting enough, metoprolol succinate can be split and is scored (i.e. has a break line in the middle of the tablet). This is uncommon among extended-release drugs and metoprolol succinate is one of the few extended-release drugs where splitting is okay.

Metoprolol succinate can be split due to how the extended-release mechanism works. Each tablet contains contains a number of small controlled release pellets, which are evenly dispersed throughout the tablet. This can be seen in the image below.

Each pellet acts as their own delivery device, and splitting the tablets will not destroy them. For this reason, the tablet can be split. However, as mentioned, the tablets cannot be crushed, as doing so will destroy these pellets.

Final Words

Thanks again for your question!

I hope this answer helped.

Please feel free to reach out to us again in the future.

References

• 
  Metoprolol Monograph,
  PubChem
  
• 
  Toprol XL prescribing Information,
  AccessFDA
  
• 
  Lopressor Prescribing Information,
  AccessFDA
  

To Crush or Not to Crush

There are multiple reasons for crushing tablets or capsule contents before administering medications, but there are numerous medications that should not be crushed. These medications should not be chewed, either, usually due to their specific formulations and their pharmacokinetic properties.1 Most of the no-crush medications are sustained-release, oral-dosage formulas. The majority of extended-release products should not be crushed or chewed, although there are some newer slow-release tablet formulations available that are scored and can be divided or halved (e.g., Toprol XL).

A common reason for crushing a tablet or capsule is for use by a hospitalized patient with an enteral feeding tube. A recent review in the American Journal of Health-System Pharmacy provides more details about administering medications in patients with enteral feeding tubes.2 Oral solutions can be used when commercially available and medically appropriate. If an oral solution or suspension is not available, the hospital pharmacy should be consulted to determine if a liquid formulation of the product can be extemporaneously prepared. In some cases, after careful consideration of compatibility, stability, and drug absorption changes, an injectable formulation of a product may be used. You should always consult your hospital pharmacist for information on this modality of drug administration.

Some patients have difficulty swallowing tablets or capsules; some dislike the taste. In these cases, crushing of medication for powdered delivery (to be mixed with food or beverages) should be considered. But beware of certain caveats, as not all medications are suitable for crushing. Generally, meds that should not be crushed fall into one of these categories:

• Sustained-release tablets, which can be composed of multiple layers for different drug release times, as can beads within capsules. Some of the more common prefixes or suffixes for sustained-release, controlled-release, or controlled-delivery products include: 12-hour, 24-hour, CC, CD, CR, ER, LA, Retard, SA, Slo-, SR, XL, XR, or XT.
• Enteric-coated tablets, which are formulated because certain drugs can be irritating to the stomach or are degraded by stomach acid. By enteric-coating tablets or capsule beads, the drug’s release can be delayed until it reaches the small intestine. Prefixes include EN- and EC-.

Other medications have objectionable tastes and are sugar-coated to improve tolerability. If this type of medication is crushed, the patient would be subject to its unpleasant taste, which could significantly impair medication adherence. Additionally, both sublingual and effervescent medications should not be crushed because it will decrease the medication’s effectiveness.

Hospital Pharmacy publishes a wall chart that includes many of these types of formulations, along with their do’s and don’ts. If there is ever any doubt about the best way to administer a particular product or whether it can be halved or crushed, ask your pharmacist.3 TH

Michele B. Kaufman, PharmD, BSc, RPh, is a freelance medical writer based in New York City.

New Generics

• Stavudine capsules (generic Zerit)4

New Drugs, Indications & Dosage Forms

Cinryze, a C1 esterase inhibitor (human), is FDA-approved as a new orphan drug for routine prophylaxis against angioedema in patients with hereditary angioedema (HAE). 5 The drug is administered intravenously (IV) and can be administered every three to four days for routine HAE attack prevention, which can spontaneously occur during stress, surgery, or infection, and lead to rapid swelling of the hands, feet, limbs, face, intestinal tract, or airway.6

Granisetron 3.1mg/24-hour transdermal patch (Sancuso) is FDA-approved for preventing nausea and vomiting in adults receiving moderate or high-chemotherapy regimens for up to five consecutive days.7 To dose the patch, apply it to a clean, dry area of intact healthy skin on the upper outer arm 24 to 48 hours before chemotherapy, and remove it at least 24 hours after chemotherapy has been completed. A patch may be worn for up to seven days. They should not be cut.

Hydrocodone bitartrate 10-mg/chlorpheniramine 8-mg (Tussicaps) is FDA-approved as a Schedule III controlled substance as an antitussive/antihistamine combination.8 Adult dosage is one capsule every 12 hours.

Lacosamide (Vimpat) is FDA-approved for add-on therapy in patients ≥17 years with uncontrolled, partial-onset seizures. 11 The starting dose is 50 mg twice daily and may be increased to a daily dose of 200-400 mg as two divided doses. The most common adverse reactions in clinical trials were diplopia, headache, dizziness, and nausea. Both the oral tablets and the IV infusion are bioequivalent.

Mesalamine extended-release 0.375-gm capsules (Apriso) is FDA-approved for once-daily dosing for the maintenance of remission of ulcerative colitis.9 Mesalamine is a local-acting aminosalicylate. The recommended dose is four capsules (1.5 g/day) in the morning with or without food. Because release of the active drug is pH-dependent, it should not be administered with antacids.

Ranolazine (Ranexa) is FDA-approved as an initial treatment for chronic angina.10 It can be used as monotherapy, in combination with beta blockers, or with other drugs.

Quetiapine extended-release tablets (Seroquel XR) are FDA-approved to treat depressive episodes in bipolar disorder, manic and mixed episodes in bipolar I disorder, and the maintenance treatment of bipolar I disorder as adjunct therapy to lithium or divalproex.